Global Migraine Drugs Market Research Report 2020

Global Migraine Drugs Market Research Report 2020

Table of Contents
1 Migraine Drugs Market Overview
1.1 Product Overview and Scope of Migraine Drugs
1.2 Migraine Drugs Segment by Type
1.2.1 Global Migraine Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Migraine Drugs Segment by Application
1.3.1 Migraine Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Migraine Drugs Revenue 2015-2026
1.4.2 Global Migraine Drugs Sales 2015-2026
1.4.3 Migraine Drugs Market Size by Region: 2020 Versus 2026
2 Global Migraine Drugs Market Competition by Manufacturers
2.1 Global Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Migraine Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Migraine Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Migraine Drugs Manufacturing Sites, Area Served, Product Type
2.5 Migraine Drugs Market Competitive Situation and Trends
2.5.1 Migraine Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Migraine Drugs Players (Opinion Leaders)
3 Migraine Drugs Retrospective Market Scenario by Region
3.1 Global Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Migraine Drugs Market Facts & Figures by Country
3.3.1 North America Migraine Drugs Sales by Country
3.3.2 North America Migraine Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Migraine Drugs Market Facts & Figures by Country
3.4.1 Europe Migraine Drugs Sales by Country
3.4.2 Europe Migraine Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Migraine Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Migraine Drugs Sales by Region
3.5.2 Asia Pacific Migraine Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Migraine Drugs Market Facts & Figures by Country
3.6.1 Latin America Migraine Drugs Sales by Country
3.6.2 Latin America Migraine Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Migraine Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Migraine Drugs Sales by Country
3.7.2 Middle East and Africa Migraine Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Migraine Drugs Historic Market Analysis by Type
4.1 Global Migraine Drugs Sales Market Share by Type (2015-2020)
4.2 Global Migraine Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Migraine Drugs Price Market Share by Type (2015-2020)
4.4 Global Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Migraine Drugs Historic Market Analysis by Application
5.1 Global Migraine Drugs Sales Market Share by Application (2015-2020)
5.2 Global Migraine Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Migraine Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Migraine Drugs Business
6.1 Allergan
6.1.1 Corporation Information
6.1.2 Allergan Description, Business Overview and Total Revenue
6.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Allergan Products Offered
6.1.5 Allergan Recent Development
6.2 Merck
6.2.1 Merck Migraine Drugs Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Pfizer
6.3.1 Pfizer Migraine Drugs Production Sites and Area Served
6.3.2 Pfizer Description, Business Overview and Total Revenue
6.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Products Offered
6.3.5 Pfizer Recent Development
6.4 Teva
6.4.1 Teva Migraine Drugs Production Sites and Area Served
6.4.2 Teva Description, Business Overview and Total Revenue
6.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Teva Products Offered
6.4.5 Teva Recent Development
6.5 Pfizer
6.5.1 Pfizer Migraine Drugs Production Sites and Area Served
6.5.2 Pfizer Description, Business Overview and Total Revenue
6.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Pfizer Products Offered
6.5.5 Pfizer Recent Development
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Migraine Drugs Production Sites and Area Served
6.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Johnson & Johnson Products Offered
6.6.5 Johnson & Johnson Recent Development
6.7 Endo International
6.6.1 Endo International Migraine Drugs Production Sites and Area Served
6.6.2 Endo International Description, Business Overview and Total Revenue
6.6.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Endo International Products Offered
6.7.5 Endo International Recent Development
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Migraine Drugs Production Sites and Area Served
6.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 GlaxoSmithKline Products Offered
6.8.5 GlaxoSmithKline Recent Development
6.9 Impax
6.9.1 Impax Migraine Drugs Production Sites and Area Served
6.9.2 Impax Description, Business Overview and Total Revenue
6.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Impax Products Offered
6.9.5 Impax Recent Development
6.10 Abbott
6.10.1 Abbott Migraine Drugs Production Sites and Area Served
6.10.2 Abbott Description, Business Overview and Total Revenue
6.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Abbott Products Offered
6.10.5 Abbott Recent Development
6.11 Bayer
6.11.1 Bayer Migraine Drugs Production Sites and Area Served
6.11.2 Bayer Migraine Drugs Description, Business Overview and Total Revenue
6.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Bayer Products Offered
6.11.5 Bayer Recent Development
6.12 Eli Lilly
6.12.1 Eli Lilly Migraine Drugs Production Sites and Area Served
6.12.2 Eli Lilly Migraine Drugs Description, Business Overview and Total Revenue
6.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Eli Lilly Products Offered
6.12.5 Eli Lilly Recent Development
6.13 Ethypharm
6.13.1 Ethypharm Migraine Drugs Production Sites and Area Served
6.13.2 Ethypharm Migraine Drugs Description, Business Overview and Total Revenue
6.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Ethypharm Products Offered
6.13.5 Ethypharm Recent Development
6.14 Kowa Pharmaceuticals America
6.14.1 Kowa Pharmaceuticals America Migraine Drugs Production Sites and Area Served
6.14.2 Kowa Pharmaceuticals America Migraine Drugs Description, Business Overview and Total Revenue
6.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Kowa Pharmaceuticals America Products Offered
6.14.5 Kowa Pharmaceuticals America Recent Development
6.15 Winston Pharmaceuticals
6.15.1 Winston Pharmaceuticals Migraine Drugs Production Sites and Area Served
6.15.2 Winston Pharmaceuticals Migraine Drugs Description, Business Overview and Total Revenue
6.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Winston Pharmaceuticals Products Offered
6.15.5 Winston Pharmaceuticals Recent Development
6.16 AstraZeneca
6.16.1 AstraZeneca Migraine Drugs Production Sites and Area Served
6.16.2 AstraZeneca Migraine Drugs Description, Business Overview and Total Revenue
6.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 AstraZeneca Products Offered
6.16.5 AstraZeneca Recent Development
7 Migraine Drugs Manufacturing Cost Analysis
7.1 Migraine Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Migraine Drugs
7.4 Migraine Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Migraine Drugs Distributors List
8.3 Migraine Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Migraine Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Migraine Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Migraine Drugs by Type (2021-2026)
10.2 Migraine Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Migraine Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Migraine Drugs by Application (2021-2026)
10.3 Migraine Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Migraine Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Migraine Drugs by Region (2021-2026)
10.4 North America Migraine Drugs Estimates and Projections (2021-2026)
10.5 Europe Migraine Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Migraine Drugs Estimates and Projections (2021-2026)
10.7 Latin America Migraine Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Migraine Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Migraine Drugs Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Migraine Drugs Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Migraine Drugs Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Migraine Drugs Manufacturers Covered in This Study
Table 5. Global Migraine Drugs Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Migraine Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Migraine Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Migraine Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Migraine Drugs Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Migraine Drugs Sales Sites and Area Served
Table 11. Manufacturers Migraine Drugs Product Types
Table 12. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Migraine Drugs Players
Table 16. Global Migraine Drugs Sales (K MT) by Region (2015-2020)
Table 17. Global Migraine Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Migraine Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Migraine Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 21. North America Migraine Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 25. Europe Migraine Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Migraine Drugs Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Migraine Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Migraine Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Migraine Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 33. Latin America Migraine Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Migraine Drugs Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Migraine Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Migraine Drugs Sales (K MT) by Type (2015-2020)
Table 41. Global Migraine Drugs Sales Share by Type (2015-2020)
Table 42. Global Migraine Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Migraine Drugs Revenue Share by Type (2015-2020)
Table 44. Global Migraine Drugs Price (USD/MT) by Type (2015-2020)
Table 45. Global Migraine Drugs Sales (K MT) by Application (2015-2020)
Table 46. Global Migraine Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Migraine Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Allergan Migraine Drugs Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Allergan Main Product
Table 52. Allergan Recent Development
Table 53. Merck Migraine Drugs Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Pfizer Migraine Drugs Corporation Information
Table 59. Pfizer Corporation Information
Table 60. Pfizer Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Pfizer Main Product
Table 62. Pfizer Recent Development
Table 63. Teva Migraine Drugs Corporation Information
Table 64. Teva Corporation Information
Table 65. Teva Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Teva Main Product
Table 67. Teva Recent Development
Table 68. Pfizer Migraine Drugs Corporation Information
Table 69. Pfizer Corporation Information
Table 70. Pfizer Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Pfizer Main Product
Table 72. Pfizer Recent Development
Table 73. Johnson & Johnson Migraine Drugs Corporation Information
Table 74. Johnson & Johnson Corporation Information
Table 75. Johnson & Johnson Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Johnson & Johnson Main Product
Table 77. Johnson & Johnson Recent Development
Table 78. Endo International Migraine Drugs Corporation Information
Table 79. Endo International Corporation Information
Table 80. Endo International Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Endo International Main Product
Table 82. Endo International Recent Development
Table 83. GlaxoSmithKline Migraine Drugs Corporation Information
Table 84. GlaxoSmithKline Corporation Information
Table 85. GlaxoSmithKline Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. GlaxoSmithKline Main Product
Table 87. GlaxoSmithKline Recent Development
Table 88. Impax Migraine Drugs Corporation Information
Table 89. Impax Corporation Information
Table 90. Impax Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Impax Main Product
Table 92. Impax Recent Development
Table 93. Abbott Migraine Drugs Corporation Information
Table 94. Abbott Corporation Information
Table 95. Abbott Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Abbott Main Product
Table 97. Abbott Recent Development
Table 98. Bayer Migraine Drugs Corporation Information
Table 99. Bayer Corporation Information
Table 100. Bayer Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Bayer Main Product
Table 102. Bayer Recent Development
Table 103. Eli Lilly Migraine Drugs Corporation Information
Table 104. Eli Lilly Corporation Information
Table 105. Eli Lilly Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Eli Lilly Main Product
Table 107. Eli Lilly Recent Development
Table 108. Ethypharm Migraine Drugs Corporation Information
Table 109. Ethypharm Corporation Information
Table 110. Ethypharm Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Ethypharm Main Product
Table 112. Ethypharm Recent Development
Table 113. Kowa Pharmaceuticals America Migraine Drugs Corporation Information
Table 114. Kowa Pharmaceuticals America Corporation Information
Table 115. Kowa Pharmaceuticals America Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Kowa Pharmaceuticals America Main Product
Table 117. Kowa Pharmaceuticals America Recent Development
Table 118. Winston Pharmaceuticals Migraine Drugs Corporation Information
Table 119. Winston Pharmaceuticals Corporation Information
Table 120. Winston Pharmaceuticals Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Winston Pharmaceuticals Main Product
Table 122. Winston Pharmaceuticals Recent Development
Table 123. AstraZeneca Migraine Drugs Corporation Information
Table 124. AstraZeneca Corporation Information
Table 125. AstraZeneca Migraine Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. AstraZeneca Main Product
Table 127. AstraZeneca Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Migraine Drugs Distributors List
Table 131. Migraine Drugs Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Migraine Drugs Sales (K MT) Forecast by Type (2021-2026)
Table 136. Global Migraine Drugs Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Migraine Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Migraine Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Migraine Drugs Sales (K MT) Forecast by Application (2021-2026)
Table 140. Global Migraine Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Migraine Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 142. Global Migraine Drugs Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Migraine Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Migraine Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Migraine Drugs
Figure 2. Global Migraine Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Sumatriptan Product Picture
Figure 4. Zolmitriptan Product Picture
Figure 5. Rizatriptan Product Picture
Figure 6. Others Drug Product Picture
Figure 7. Global Migraine Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Household Use
Figure 11. Others
Figure 12. Global Migraine Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Migraine Drugs Sales Capacity (K MT) (2015-2026)
Figure 14. Global Migraine Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Migraine Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Migraine Drugs Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Migraine Drugs Revenue in 2019
Figure 18. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Migraine Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Migraine Drugs Sales Market Share by Region in 2019
Figure 21. Global Migraine Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Migraine Drugs Revenue Market Share by Region in 2019
Figure 23. North America Migraine Drugs Sales Market Share by Country in 2019
Figure 24. North America Migraine Drugs Revenue Market Share by Country in 2019
Figure 25. U.S. Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 26. U.S. Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 28. Canada Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Migraine Drugs Sales Market Share by Country in 2019
Figure 30. Europe Migraine Drugs Revenue Market Share by Country in 2019
Figure 31. Germany Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 32. Germany Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. France Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.K. Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. Italy Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 40. Russia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Migraine Drugs Sales Market Share by Region in 2019
Figure 42. Asia Pacific Migraine Drugs Revenue Market Share by Region in 2019
Figure 43. China Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. China Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Japan Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. South Korea Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. India Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Australia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Taiwan Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. Indonesia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 58. Thailand Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. Malaysia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Philippines Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. Vietnam Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Migraine Drugs Sales Market Share by Country in 2019
Figure 66. Latin America Migraine Drugs Revenue Market Share by Country in 2019
Figure 67. Mexico Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Mexico Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Brazil Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Migraine Drugs Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Migraine Drugs Revenue Market Share by Country in 2019
Figure 75. Turkey Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Turkey Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Saudi Arabia Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Migraine Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. U.A.E Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Migraine Drugs by Type (2015-2020)
Figure 82. Sales Market Share of Migraine Drugs by Type in 2019
Figure 83. Revenue Share of Migraine Drugs by Type (2015-2020)
Figure 84. Revenue Market Share of Migraine Drugs by Type in 2019
Figure 85. Global Migraine Drugs Sales Growth by Type (2015-2020) (K MT)
Figure 86. Global Migraine Drugs Sales Market Share by Application (2015-2020)
Figure 87. Global Migraine Drugs Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Migraine Drugs by Application (2015-2020)
Figure 89. Global Revenue Share of Migraine Drugs by Application in 2020
Figure 90. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Impax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Ethypharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Kowa Pharmaceuticals America Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Winston Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Migraine Drugs
Figure 108. Manufacturing Process Analysis of Migraine Drugs
Figure 109. Migraine Drugs Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Migraine Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. North America Migraine Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Migraine Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Migraine Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Migraine Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Migraine Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Migraine Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Migraine Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Migraine Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Migraine Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Narcolepsy Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80

According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......

Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......

Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......

Migraine Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......

Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......

Global Edaravone Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......

Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......

Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs